Sudbury, MA, United States of America

Giuseppe Ciaramella

USPTO Granted Patents = 53 

 

Average Co-Inventor Count = 2.3

ph-index = 20

Forward Citations = 1,372(Granted Patents)

Forward Citations (Not Self Cited) = 825(Oct 12, 2025)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
53 patents (USPTO):Explore Patents

Title: Giuseppe Ciaramella: Pioneering Innovator in Biomedical Technology

Introduction:

Giuseppe Ciaramella is a distinguished inventor located in Sudbury, MA (US) known for his remarkable contributions to the field of biomedical technology. With an impressive portfolio of 43 patents, Giuseppe's work has significantly advanced the realm of nucleic acid vaccines.

Latest Patents:

Among his recent patents is the Varicella zoster virus (VZV) vaccine, focusing on nucleic acid vaccines containing RNA polynucleotides encoding VZV antigens. Additionally, he has made strides in RSV RNA vaccines, utilizing lipid nanoparticles for effective formulation.

Career Highlights:

Giuseppe's career is adorned with impactful endeavors, including his roles at renowned companies like Modernatx, Inc. and Vanderbilt University. At Modernatx, Inc., he played a pivotal role in driving innovation and research in the development of novel vaccine technologies.

Collaborations:

Throughout his career, Giuseppe has collaborated with notable professionals in the industry, such as Sunny Himansu and Eric Yi-Chun Huang. Together, they have worked synergistically to bring forth groundbreaking advancements in the field of biomedical technology.

Conclusion:

In conclusion, Giuseppe Ciaramella emerges as a true visionary and pioneer in the world of innovation, consistently pushing the boundaries of what is achievable in biomedical technology. His dedication to creating a better future through technological advancements is truly commendable, leaving a lasting impact on the landscape of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…